Cardiovascular Monitoring and Diagnostic Devices Market to Witness Robust Growth

Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity, generally by electrocardiography, with assessment of the patient's condition relative to their cardiac rhythm. ECG monitoring devices, Holter monitoring devices, ECG stress testing devices, and event monitoring devices are discussed in the report.

The cardiovascularmonitoring and diagnostic devices market is witnessing strong growth in North America, owing to the increasing prevalence of cardiovascular diseases in the region. According to the Centers for Disease Control and Prevention (CDC), one person dies every 36 seconds from cardiovascular disease in the United States. Around 655,000 people (one in every four) in the U.S. die from heart disease each year. Cardiovascular disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. Thus, there is an increasing demand for cardiovascular monitoring and diagnostic devices in North America, especially in the United States.

Comments

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth. Increasing preva...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

A biologic drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket .

Breathalyzers Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028

The breathalyzer market refers to the sales and distribution of devices used for measuring blood alcohol content (BAC) through analysis of a breath sample. These devices are widely used by law enforcement agencies for detecting drunk drivers and in workplaces for alcohol screening. The market has been growing due to increasing awareness about the dangers of drunk driving, stricter laws and penalties, and advancements in technology that have made breathalyzers more portable and user-friendly. The market is expected to continue growing in the future as demand for personal and professional use breathalyzers increases. Breathalyzers are instruments used for testing blood alcohol levels through an individual’s breath. These devices find application in probation departments, police departments, remand homes, and commercial sector. The global breathalyzers market is estimated to account for US$ 6,384.5 Mn in terms of value in 2020 and is expected to reach US$ 71,8...

Healthcare News

Search This Blog